Evidence-based value and access strategies

Principals: Nicolas Touchot


Nnicolas_touchoticolas Touchot, PhD
Europe Lead

Nicolas holds a Ph.D. in Molecular Biology from the Pierre et Marie Curie University in France and an MBA from the Kellogg Graduate School of Management. Nicolas has more than 20 years of experience in the biopharma and consulting industries and was until recently a Managing Director at Easton Associates.

Before being a consultant, Nicolas gained industry experience through the European management of Johnson & Johnson Interventional Systems where he specialized in market development and clinical testing. Earlier in his career, he worked as a research scientist for Princeton University.

Nicolas regularly speaks at conferences on Market Access, most recently at the SMI COPD and Asthma conference (London, April 2014) and contributes to the EMAUD (European Market Access Master Diploma). He is one of the very few non-payers invited to participate to the Payers’ Insight Network, an emerging information exchange platform dedicated to Health Technology Assessment and coverage decisions.

Nicolas is also the author of these recent articles: A Call for Action: Integrating Payer Requirements Into Phase III Clinical TrialsIn Vivo, June 2011; Pharma Strategies for the Development of Payer Evidence Programs – In Vivo, February 2012, and Projecting Market Access Success For Early-Stage Pharma Assets – In Vivo, February 2013; and The Payer’s Perspective on Gene therapies – Nature Biotechnology, September 2015

Nicolas, located in France, is an expert in pricing and access in Europe.

Meet Our Principals

Paul GallagherPaul Gallagher, MBA
President

Barbara Pannone, PhD
VP, Consulting Strategy and Operations

SM_maximilian-vargasMaximilian Vargas, PhD, MBA
VP, Consulting Strategy and Account Management

SM_EdGallagherEdward Gallagher, MS
Global Pricing Strategy Leader

SM_nicolas_touchotNicolas Touchot, PhD
Europe Lead